Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2011-08-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/ard.2010.147140PMID 21873331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of basic fibroblast growth factor-stimulated VEGF synthesis by Wnt3a in osteoblasts.

  2011cited by this paper
• Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability.

  2011cited by this paper
• Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

  2011cited by this paper
• Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

  2011cited by this paper
• Animal models of systemic sclerosis: prospects and limitations.

  2010cited by this paper
• GSK3: a multifaceted kinase in Wnt signaling.

  2010cited by this paper
• Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.

  2010cited by this paper
• Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones

  2010cited by this paper
• The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.

  2010cited by this paper
• Scleroderma.

  2009cited by this paper
• Towards an integrated view of Wnt signaling in development

  2009cited by this paper
• Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment1

  2009cited by this paper
• The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

  2009cited by this paper
• Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development*

  2009cited by this paper
• Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.

  2009cited by this paper
• Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis.

  2008influential reference
• Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

  2008cited by this paper
• Supernatant from Bifidobacterium Differentially Modulates Transduction Signaling Pathways for Biological Functions of Human Dendritic Cells

  2008cited by this paper
• Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

  2008cited by this paper
• GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanism.

  2008cited by this paper
• Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.

  2007cited by this paper
• Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.

  2007cited by this paper
• Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.

  2007cited by this paper
• Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors*

  2006cited by this paper
• Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.

  2005cited by this paper
• The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles.

  2005cited by this paper
• The Wnt signaling pathway in development and disease.

  2004influential reference
• Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418*

  2003cited by this paper
• Criteria for the classification of early systemic sclerosis.

  2001cited by this paper
• Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

  2000cited by this paper
• Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus.

  2000cited by this paper
• The oncogenic activation of β-catenin

  1999cited by this paper
• The oncogenic activation of beta-catenin.

  1999cited by this paper
• Tight-skin mouse an experimental model for scleroderma.

  1994cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

  1961cited by this paper

• Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis.

  2026cites this paper
• Investigating the effect of Lactobacillus crispatus extract on the expression of Axin2 and GSK3β genes from Wnt pathway in uterine cell line

  2025cites this paper
• Antifibrotic therapeutic strategies in systemic sclerosis: Critical role of the Wnt/β-catenin and TGF-β signal transduction pathways as potential targets.

  2025cites this paper
• The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.

  2024cites this paper
• The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon?

  2023cites this paper
• Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.

  2023cites this paper
• Pharmacotherapy of urethral stricture

  2023cites this paper
• Tankyrase: a promising therapeutic target with pleiotropic action

  2023cites this paper
• Positive Feedback Loops between Fibroblasts and the Mechanical Environment Contribute to Dermal Fibrosis.

  2023cites this paper
• Radiation-induced pulmonary fibrosis: roles of therapy-induced senescence and microRNAs

  2023cites this paper
• A broad look into the future of systemic sclerosis

  2022cites this paper
• Dickkopf-1 as a promising therapeutic target for autoimmune diseases.

  2022cites this paper
• Hastatoside attenuatescarbon tetrachloride-induced liver fibrosis by targeting glycogen synthase kinase-3β.

  2022cites this paper
• Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis

  2022cites this paper
• Indirubin-3'-alkoxime derivatives for upregulation of Wnt signaling through dual inhibition of GSK-3β and the CXXC5-Dvl interaction.

  2022cites this paper
• Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis

  2021cites this paper
• Exposure to Δ9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life

  2021cites this paper
• Ferulic Acid Induces Keratin 6α via Inhibition of Nuclear β-Catenin Accumulation and Activation of Nrf2 in Wound-Induced Inflammation

  2021cites this paper
• Endoplasmic reticulum stress promotes epithelial-mesenchymal transition via the PERK signaling pathway in paraquat-induced pulmonary fibrosis

  2021cites this paper
• The role of Wnt signaling in skin fibrosis

  2021cites this paper
• TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target

  2021cites this paper
• X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)

  2021cites this paper
• Cytotoxicity and Collagen Expression Effects of Tideglusib Administration on Human Periodontal Cells: An In-Vitro Study

  2020cites this paper
• miR‐145 attenuates cardiac fibrosis through the AKT/GSK‐3β/β‐catenin signaling pathway by directly targeting SOX9 in fibroblasts

  2020cites this paper
• Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response

  2020cites this paper
• Relationship of Wnt pathway activity and organ involvement in scleroderma types

  2020cites this paper
• Red-COLA1: a human fibroblast reporter cell line for type I collagen transcription

  2020cites this paper
• Cellular and molecular mechanisms in fibrosis

  2020cites this paper
• Formulation and Evaluation of Binahong Leaves Extract Gel on Wound Healing of the Palatal Mucosa

  2020cites this paper
• Therapeutic molecular targets of SSc-ILD

  2020cites this paper
• SUMOylated TβL1/TβLR1 interacts with β-catenin in palmar fascia fibrosis: a novel therapeutic target

  2019cites this paper
• Fibrillin microfibrils and proteases, key integrators of fibrotic pathways.

  2019cites this paper
• Citrullination of fibronectin alters integrin clustering and focal adhesion stability promoting stromal cell invasion.

  2019cites this paper
• Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists

  2019cites this paper
• Exogenous H2S mitigates myocardial fibrosis in diabetic rats through suppression of the canonical Wnt pathway

  2019cites this paper
• Shared and distinct mechanisms of fibrosis

  2019cites this paper
• TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts

  2019cites this paper
• Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis

  2019cites this paper
• Inhibition of GSK‐3β induces AP‐1‐mediated osteopontin expression to promote cholestatic liver fibrosis

  2018cites this paper
• The WNT signaling pathways in wound healing and fibrosis.

  2018cites this paper
• Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress

  2018cites this paper
• Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model

  2018cites this paper
• Targeting TGF-β signaling for the treatment of fibrosis.

  2018cites this paper
• Epigenetic factors as drivers of fibrosis in systemic sclerosis.

  2017cites this paper
• The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?

  2017cites this paper
• Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling

  2017cites this paper
• The Myofibroblast: TGFβ-1, A Conductor which Plays a Key Role in Fibrosis by Regulating the Balance between PPARγ and the Canonical WNT Pathway

  2017cites this paper
• Modulating the wnt signaling pathway with small molecules

  2017cites this paper
• Feedback Activation of Basic Fibroblast Growth Factor Signaling via the Wnt/β-Catenin Pathway in Skin Fibroblasts

  2017cites this paper
• Biochemical and biomechanical regulation of the myofibroblast phenotype : focus on Hippo and TGFβ signaling

  2017cites this paper
• Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.

  2017influential citation
• Updates on animal models of systemic sclerosis

  2016cites this paper
• The comparison of the Wnt signaling pathway inhibitor delivered electrospun nanoyarn fabricated with two methods for the application of urethroplasty

  2016cites this paper
• Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment

  2016cites this paper
• The Effect of rhCygb on CCl4-Induced Hepatic Fibrogenesis in Rat

  2016cites this paper
• Canonical Wnt signaling in systemic sclerosis

  2016cites this paper
• Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases

  2016cites this paper
• B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis

  2016cites this paper
• Animal Models of Systemic Sclerosis

  2016cites this paper
• Functional Effects of WNT1-Inducible Signaling Pathway Protein-1 on Bronchial Smooth Muscle Cell Migration and Proliferation in OVA-Induced Airway Remodeling

  2015cites this paper
• Animal models of systemic sclerosis.

  2015cites this paper
• From pathogenesis to therapy--Perspective on treatment strategies in fibrotic diseases.

  2015cites this paper
• Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis

  2015cites this paper
• Inhibition of glycogen synthase kinase-3β prevents sympathetic hyperinnervation in infarcted rats

  2015cites this paper
• The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing

  2015cites this paper
• Fibrogenesis, novel lessons from animal models

  2015cites this paper
• The GSK-3 family as therapeutic target for myocardial diseases.

  2015cites this paper
• Morphogen and epigenetic regulation of wound healing

  2015influential citation
• Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.

  2015cites this paper
• Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge

  2015cites this paper
• The roles of AXIN2 in tumorigenesis and epigenetic regulation

  2015cites this paper
• Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study

  2015cites this paper
• Integrins and cadherins as therapeutic targets in fibrosis

  2014cites this paper
• Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo

  2014cites this paper
• Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability

  2014cites this paper
• Antiarrhythmic effect of lithium in rats after myocardial infarction by activation of Nrf2/HO-1 signaling.

  2014cites this paper
• S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis

  2014cites this paper
• Valvular interstitial cell transformation : implications for aortic valve calcification

  2014cites this paper
• Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

  2014cites this paper
• Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?

  2013cites this paper
• Scleroderma: recent lessons from murine models and implications for future therapeutics

  2013cites this paper
• Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

  2013cites this paper
• Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling

  2013cites this paper
• Canonical Wnt signalling as a key regulator of fibrogenesis – implications for targeted therapies?

  2013cites this paper
• Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat

  2013cites this paper
• Systemic sclerosis: a critical digest of the recent literature.

  2013cites this paper
• The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

  2013cites this paper
• A role for WNT1-inducible signaling protein-1 in airway remodeling in a rat asthma model.

  2013cites this paper
• Wnt/beta-catenin signaling: a promising new target for fibrosis diseases.

  2012cites this paper
• Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

  2012cites this paper
• Innovative antifibrotic therapies in systemic sclerosis

  2012cites this paper
• Role of MicroRNAs in Fibrosis

  2012cites this paper
• β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

  2012cites this paper
• Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.

  2012cites this paper
• Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis

  2012cites this paper
• Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.

  2012cites this paper
• Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.

  2012cites this paper
• Updates on the pathophysiology of dermal sclerosis

  2012cites this paper
• Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling

  2012cites this paper
• Morphogen Pathways in Systemic Sclerosis

  2012cites this paper